Bibliography
- Peyvandi F, Duga S, Akhavan S, Rare coagulation deficiencies. Haemophilia 2002;8:308-21
- Peyvandi F, Jayandharan G, Chandy M, Genetic diagnosis of haemophilia and other inherited bleeding disorders. Haemophilia 2006;12:82-9
- Bolton-Maggs PH, Pasi KJ. Haemophilias A and B. Lancet 2003;361:1801-9
- White GC II, Beebe A, Nielsen B. Recombinant factor IX. Thromb Haemost 1997;78:261-5
- Kootstra NA, Matsumura R, Verma IM. Efficient production of human FVIII in hemophilic mice using lentiviral vectors. Mol Ther 2003;7:623-31
- Wang L, Calcedo R, Nichols TC, Sustained correction of disease in naive and AAV2-pretreated hemophilia B dogs: AAV2/8-mediated, liver-directed gene therapy. Blood 2005;105:3079-86
- Doering CB, Archer D, Spencer HT. Delivery of nucleic acid therapeutics by genetically engineered hematopoietic stem cells. Adv Drug Deliv Rev 2010;62:1204-12
- Masuda A, Yoshida M, Shiomi H, Role of Fc Receptors as a therapeutic target. Inflamm Allergy Drug Targets 2009;8:80-6
- Goebl NA, Babbey CM, Datta-Mannan A, Neonatal Fc receptor mediates internalization of Fc in transfected human endothelial cells. Mol Biol Cell 2008;19:5490-505
- Dumont JA, Low SC, Peters RT, Monomeric Fc fusions: impact on pharmacokinetic and biological activity of protein therapeutics. BioDrugs 2006;20:151-60
- Peters RT, Low SC, Kamphaus GD, Prolonged activity of factor IX as a monomeric Fc fusion protein. Blood 2010;115:2057-64
- Lin HF, Maeda N, Smithies O, A coagulation factor IX-deficient mouse model for human hemophilia B. Blood 1997;90:3962-6
- Roopenian DC, Christianson GJ, Sproule TJ, The MHC class I-like IgG receptor controls perinatal IgG transport, IgG homeostasis, and fate of IgG-Fc-coupled drugs. J Immunol 2003;170:3528-33
- Evans JP, Brinkhous KM, Brayer GD, Canine hemophilia B resulting from a point mutation with unusual consequences. Proc Natl Acad Sci USA 1989;86:10095-9
- Bitonti AJ, Dumont JA. Pulmonary administration of therapeutic proteins using an immunoglobulin transport pathway. Adv Drug Deliv Rev 2006;58:1106-18
- Taupin P. Ex vivo fucosylation of stem cells to improve engraftment: WO2004094619. Expert Opin Ther Pat 2010;20:1265-9
- Taupin P. Transplantation of cord blood stem cells for treating hematologic diseases and strategies to improve engraftment. Therapy 2010;7:703-15
- Taupin P. Antibodies against CD20 (Rituximab) for treating multiple sclerosis: US20100233121. Expert Opin Ther Pat 2011;21:111-14
- Napolitano LM. Scope of the problem: epidemiology of anemia and use of blood transfusions in critical care. Crit Care 2004;8:S1-8